Cite
HARVARD Citation
Fulgenzi, C. et al. (2022). Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study. European journal of cancer. pp. 204-213. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fulgenzi, C. et al. (2022). Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study. European journal of cancer. pp. 204-213. [Online].